Novan, a spinout from UNC-Chapel Hill, has closed on $6 million in new capital, according to a filing with the SEC.

Investors include Cree co-founder Neal Hunter, Cree executive John Palmour and former life science executive Robert Ingram.

Novan is focused on products to counter drug-resistant infections.

Dr. Mark Schoenfish of UNC-CH is a co-founder.

Novan raised $4 million in January.

The latest funding is a mix of equity and options, according to the SEC filing.

Get the latest news alerts: Follow WRAL Tech Wire at Twitter.